Group 1 - The core point of the announcement is the approval of the 2024 annual profit distribution plan by the company's shareholders, which includes a cash dividend distribution of 0.40 RMB per 10 shares [1][3]. - The total number of shares for the distribution is 3,034,636,384, resulting in a total cash dividend payout of 121,385,455.36 RMB (including tax) [1][2]. - The dividend distribution will not include stock bonuses or capital reserve transfers to increase share capital, and the company plans to maintain the per-share distribution ratio even if the total number of shares changes due to actions like issuance or repurchase before the dividend record date [1][2]. Group 2 - The record date for the dividend distribution is set for July 24, 2025, and the ex-dividend date is July 25, 2025 [2]. - The distribution will be made directly to the accounts of all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shenzhen Branch, as of the record date [2]. - The company will not withhold individual income tax for certain investors, and tax rates will vary based on the holding period of the shares [1][2].

证券代码：000718 证券简称：苏宁环球 公告编号：2025-020 苏宁环球股份有限公司 二、权益分派方案 本公司 2024 年年度权益分派方案为:以公司现有总股本 3,034,636,384 股为基数，向全体股东每 10 股派 0.400000 元人民币现 金（含税；扣税后，通过深股通持有股份的香港市场投资者、境外机 构（含 QFII、RQFII）以及持有首发前限售股的个人和证券投资基金每 10 股派 0.360000 元；持有首发后限售股、股权激励限售股及无限售 流通股的个人股息红利税实行差别化税率征收，本公司暂不扣缴个人 所得税，待个人转让股票时，根据其持股期限计算应纳税额【注】； 持有首发后限售股、股权激励限售股及无限售流通股的证券投资基金 所涉红利税，对香港投资者持有基金份额部分按 10%征收，对内地投 资者持有基金份额部分实行差别化税率征收）。 【注：根据先进先出的原则，以投资者证券账户为单位计算持股 期限，持股 1 个月（含 1 个月）以内，每 10 股补缴税款 0.080000 元； 持股 1 个月以上至 1 年（含 1 年）的，每 10 股补缴税款 0.040000 元； 持股超过 1 ...

证券代码：000718 证券简称：苏宁环球 公告编号：2025-019 苏宁环球股份有限公司 关于为子公司申请银行授信提供担保的 进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、担保情况概述 苏宁环球股份有限公司（以下简称"公司"）第十一届董事会第 七次会议、第十一届监事会第七次会议、2024 年年度股东大会，审 议通过了《关于 2025 年对子公司预计担保额度的议案》，公司、全 资子公司及控股子公司（包括但不限于净资产负债率超过 70%的子公 司），拟在 2025 年度向金融机构融资，公司及子公司（含控股子公 司）拟为其银行及其它金融机构信贷业务以及其它业务提供担保，在 授权有效期内提供的担保总额不超过人民币 38.2 亿元。实际担保金 额、种类、期限等以合同为准，授权经营管理层具体办理相关事宜， 有效期自本事项经公司 2024 年年度股东大会审议批准之日起至 2025 年年度股东大会审议之日止。 具体内容详见公司于巨潮资讯网 http://www.cninfo.com.cn 披露 的《关于2025 年对子公司预计担保额度的公告》（公告编号：2 ...

Group 1: Company Overview and Strategy - The company focuses on real estate development and sales, with a strong presence in the Yangtze River Delta region, adhering to a "long-termism" philosophy and a strategy of "steady operation and progress" [2][3] - The company maintains a "low debt, high return" operational strategy while advancing its dual business model in real estate and medical aesthetics [2][3] Group 2: Real Estate Business Performance - The real estate sector remains under pressure, but market sales data is stabilizing; the company benefits from ample quality land reserves and low land costs, with a total land reserve of over 1.7 million square meters [3] - Key projects like Binjiang Yayuan and Rongjin Ruifu are performing well, with strong sales and high profitability [3][4] Group 3: Future Development Plans in Real Estate - The company plans to continue its high-profit and positive cash flow real estate projects, with new projects set to launch in advantageous areas in the second half of the year [4] - The company will focus on upgrading and launching premium projects while maintaining a stable pricing system [4] Group 4: Medical Aesthetics Business Performance - The company has established six medical aesthetics institutions, creating a distribution pattern across six cities, and is committed to compliance and quality management [5][6] - The revenue and profit from the medical aesthetics sector are gradually increasing, with expectations for significant growth in revenue share by 2026 as new institutions open in the Yangtze River Delta [6] Group 5: Market Conditions and Future Outlook for Medical Aesthetics - The medical aesthetics market is experiencing a slowdown, with increased concentration and the exit of smaller players; however, the company focuses on high-end clientele and maintains a stable pricing strategy [7][8] - The company aims to expand its medical aesthetics business while exploring new industries and opportunities for sustainable growth [8]

Group 1: Medical Aesthetics Business Development - The company plans to increase investment in the medical aesthetics sector, aiming to enhance the market recognition and reputation of the Suya Medical Aesthetics brand. In 2025, new medical aesthetics institutions are planned to open in Jiangsu and Shanghai [2][3] - In 2024, the medical aesthetics segment achieved revenue of 179 million yuan and is currently profitable. The company will continue to focus on self-built facilities and expand in high-consumption areas like the Yangtze River Delta [5][6] Group 2: Shareholder Engagement and Stock Performance - In 2024, the actual controller and some executives completed a round of share buybacks, demonstrating confidence in the company's long-term investment value [3][4] - The company is committed to a "long-termism" approach, focusing on stable operations and long-term value creation, despite current market pressures affecting stock prices [4][6] Group 3: Strategic Business Direction - The company is dedicated to developing medical aesthetics and biopharmaceuticals, emphasizing a long-term strategy and resource optimization to enhance operational efficiency and profitability [3][5] - Future business expansion will include exploring new industries and opportunities, with a focus on maintaining a balanced approach to growth and avoiding reckless expansion [5][6] Group 4: Market Conditions and Company Response - The company's stock price has been under pressure due to macroeconomic factors, industry developments, and investor expectations. The company aims to improve product quality, brand building, and customer service to enhance overall competitiveness [6][7] - New medical aesthetics facilities are under construction, with plans for trial operations expected around mid-year [6][7]

Meeting Details - The meeting was held on May 26, 2025, at 14:30, at Suning Global International Center, Nanjing [1] - A total of 288 shareholders and their proxies attended the meeting, representing 62,940,554 shares, which is 2.0741% of the total shares [1][2] Voting Results - The meeting approved the proposals with a total of 1,578,322,418 shares in favor, accounting for 99.8570% of the votes [2] - Among minority shareholders, 60,680,443 shares voted in favor, representing 96.4091% of their voting rights [2] - The voting results showed a consistent trend of high approval rates across multiple proposals, with votes in favor ranging from 99.8553% to 99.8756% [3][4][5][6] Legal Compliance - The meeting complied with all relevant laws, regulations, and the company's articles of association, ensuring the legitimacy of the voting process and results [9]

苏宁环球股份有限公司 2024 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 重要提示： 1、本次会议无否决议案的情况； 2、本次会议不涉及变更前次股东大会决议的情况。 一、会议召开和出席情况 1、会议的召开情况： （1）召开时间： 证券代码：000718 证券简称：苏宁环球 公告编号：2025-018 现场会议时间：2025 年 5 月 26 日（星期一）下午 14:30； 网络投票时间：通过深圳证券交易所交易系统进行网络投票的具 体时间为：2025 年 5 月 26 日上午 9:15—9:25，9:30—11:30，下午 13:00—15:00；通过深圳证券交易所互联网投票系统投票的具体时间 为：2025 年 5 月 26 日上午 9:15—下午 15:00。 （2）召开地点：江苏省南京市鼓楼区集庆门大街 270 号苏宁环 球国际中心 49 楼会议室。 （3）召开方式：现场投票与网络投票相结合。 （4）会议召集人：公司董事会。 （5）会议主持人：董事长张桂平先生。 本次会议的召开符合有关法律、行政法规、部门规章、规范性文 件和公司 ...

北京市时代九和律师事务所（以下简称"本所"）根据苏宁环球股份有限公司 （以下简称"贵公司"）的委托，指派律师出席贵公司2024年年度股东大会（以下 简称"本次股东大会"）。本所律师依据《中华人民共和国公司法》（以下简称"《公 司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、中国证券 监督管理委员会（以下简称"中国证监会"）《上市公司股东会规则（2025修订）》 等相关法律、法规、规范性文件以及《苏宁环球股份有限公司章程》（以下简称 "《公司章程》"）的有关规定，出具本法律意见书。 本所及经办律师依据《证券法》、《律师事务所从事证券法律业务管理办法》 和《律师事务所证券法律业务执业规则（试行）》等规定及本法律意见书出具日 以前已经发生或者存在的事实，严格履行了法定职责，遵循了勤勉尽责和诚实信 用原则，进行了充分的核查验证，保证本法律意见书所认定的事实真实、准确、 完整，所发表的结论性意见合法、准确，不存在虚假记载、误导性陈述或者重大 遗漏，并承担相应法律责任。 关于苏宁环球股份有限公司 2024 年年度股东大会的法律意见书 北京市时代九和律师事务所关于苏宁环球股份有限公司 2024 年年度股东大 ...

证券代码：000718 证券简称：苏宁环球 公告编号：2025-017 苏宁环球股份有限公司 关于参加 2025 年吉林辖区上市公司投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 2025 年 5 月 27 日（星期二）15:00-16:30。 二、投资者参与方式及出席人员 本次活动将采用网络远程的方式举行，投资者可登录"全景路演" 网站（http://rs.p5w.net），或关注微信公众号（名称：全景财经）， 或下载全景路演 APP，参与本次互动交流。届时公司董事长张桂平先 生，董事、副总裁、董事会秘书蒋立波先生，财务负责人刘得波先生， 将通过网络在线问答互动的形式，就公司 2024 年度业绩、公司治理、 发展战略、经营状况等投资者关心的问题，与投资者进行沟通与交流。 期间，公司高管将全程在线，实时回答投资者的提问。 欢迎广大投资者踊跃参与！ 特此公告。 苏宁环球股份有限公司董事会 为进一步加强与投资者的互动交流，苏宁环球股份有限公司（以 下简称"公司"）将参加由吉林省证券业协会、深圳市全景网络有限 公司共同举办的"202 ...

Core Viewpoint - The company, Suning Universal, emphasizes the accuracy and completeness of its quarterly report, ensuring no false records or misleading statements are present [1][2]. Financial Data Summary - The quarterly report has not been audited [3][7]. - There are no adjustments or restatements required for previous accounting data [3]. - The company does not have any non-recurring profit and loss items applicable for this quarter [3]. Shareholder Information - The total number of ordinary shareholders and the status of preferred shareholders are not applicable for this report [5]. - There are no changes in the top ten shareholders or their shareholding due to securities lending activities [5]. Other Important Matters - There are no other significant matters reported for this quarter [6]. - The company has not adopted new accounting standards for this reporting period [7].